Search research articles
Contact Us
Filters
Showing results (141-150 of 227) with videos related to
Page
of 23
Sort By:
American Journal of Surgery
|
November 28, 1997
Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer
H J Wanebo, P Chougule, W L Akerley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay
Primo N Lara, James Moon, Paul J Hesketh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 11, 2018
Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary <i>Haemophilus influenzae</i> infection
Wenchao Li, Xinyun Zhang, Ying Yang, et al.
JAMA Oncology
|
February 11, 2016
Familial Risk in Patients With Carcinoma of Unknown Primary
N Jewel Samadder, Ken Robert Smith, Heidi Hanson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity
M A Socinski, C Zhang, J E Herndon, et al.
BMC Infectious Diseases
|
January 1, 2015
A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial
Katerina A Christopoulos, Elise D Riley, Jacqueline Tulsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2007
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B
Everett E Vokes, James E Herndon, Michael J Kelley, et al.
Clinical Lung Cancer
|
November 21, 2024
Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung Cancer
Yeonjung Jo, Sonam Puri, Benjamin Haaland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 8, 2013
Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma
Christopher J Anker, Antoni Ribas, Allie H Grossmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 5, 2009
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer
Thomas E Stinchcombe, Lydia Hodgson, James E Herndon, et al.
Page
of 23
Search research articles
Search
Showing results (141-150 of 227) with videos related to
Sort By:
Page
of 23
American Journal of Surgery
|
November 28, 1997
Preoperative chemoradiation coupled with aggressive resection as needed ensures near total control in advanced head and neck cancer
H J Wanebo, P Chougule, W L Akerley, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
January 4, 2016
SWOG S0709: Randomized Phase II Trial of Erlotinib versus Erlotinib Plus Carboplatin/Paclitaxel in Patients with Advanced Non-Small Cell Lung Cancer and Impaired Performance Status as Selected by a Serum Proteomics Assay
Primo N Lara, James Moon, Paul J Hesketh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 11, 2018
Recognition of conserved antigens by Th17 cells provides broad protection against pulmonary <i>Haemophilus influenzae</i> infection
Wenchao Li, Xinyun Zhang, Ying Yang, et al.
JAMA Oncology
|
February 11, 2016
Familial Risk in Patients With Carcinoma of Unknown Primary
N Jewel Samadder, Ken Robert Smith, Heidi Hanson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
June 19, 2004
Combined modality trials of the Cancer and Leukemia Group B in stage III non-small-cell lung cancer: analysis of factors influencing survival and toxicity
M A Socinski, C Zhang, J E Herndon, et al.
BMC Infectious Diseases
|
January 1, 2015
A text messaging intervention to improve retention in care and virologic suppression in a U.S. urban safety-net HIV clinic: study protocol for the Connect4Care (C4C) randomized controlled trial
Katerina A Christopoulos, Elise D Riley, Jacqueline Tulsky, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 4, 2007
Induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for regionally advanced unresectable stage III Non-small-cell lung cancer: Cancer and Leukemia Group B
Everett E Vokes, James E Herndon, Michael J Kelley, et al.
Clinical Lung Cancer
|
November 21, 2024
Augmenting Prognostication: Utilizing Activity Trackers to Enhance Survival Prediction in Metastatic Non-Small Cell Lung Cancer
Yeonjung Jo, Sonam Puri, Benjamin Haaland, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 8, 2013
Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma
Christopher J Anker, Antoni Ribas, Allie H Grossmann, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
August 5, 2009
Treatment outcomes of different prognostic groups of patients on cancer and leukemia group B trial 39801: induction chemotherapy followed by chemoradiotherapy compared with chemoradiotherapy alone for unresectable stage III non-small cell lung cancer
Thomas E Stinchcombe, Lydia Hodgson, James E Herndon, et al.
Page
of 23